Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 600 participants.
Also called NCT05247424
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT05247424
-
- Other papers using this trial's data
- Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Slovenia
- Registry status
- Completed
Technical summary
Registry record NCT05247424. Randomized; single masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2025-02-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
- Acronym
- UFH-STEMI
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Unfractionated heparin
- Lead sponsor
- University Medical Centre Ljubljana
Record details
- Record id
cardio:ct-nct05247424- Content hash
3cc0e2a5e4d047d58e808e936df470557474c26d9f4e47fc3bbb068e1a5b97c8